Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if topical steroids treatment for different skin diseases suppress the adrenal cortisol production.


Clinical Trial Description

Adrenocortical suppression is a potential complication of systemic corticosteroid treatement but also of non systemic therapy like topical therapy.

The normalcy of hypothalamic-pituitary-adrenal axis ( HPA axis) of patients with chronic skin diseases like atopic dermatitis, pemphigus or psoriasis which are treated with topical steroids, will be assessed with the low dose (1mcg) adrenocortocotropin ( ACTH) stimulation test. During this test serum cortisol levels are measured before, 30 and 60 mn after intravenous administration of 1mcg of ACTH (synacthen).The results will be compared with age and sex matched subjects with normal HPA axis as assessed by low dose ACTH stimulation test. ;


Study Design

Observational Model: Case Control, Primary Purpose: Screening, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00476489
Study type Observational
Source HaEmek Medical Center, Israel
Contact Avraham Ishay, MD
Phone 972-4-6495556
Email ishay_av@clalit.org.il
Status Recruiting
Phase N/A
Start date May 2007